Search

Your search keyword '"Jensen, Tomas O"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Jensen, Tomas O" Remove constraint Author: "Jensen, Tomas O"
32 results on '"Jensen, Tomas O"'

Search Results

1. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

2. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

3. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

5. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

6. Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study

7. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

8. Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort Study.

10. Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

13. Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID-19

14. Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID‐19

15. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial

16. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

18. Neurological Complications in COVID-19 Patients:Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series

19. Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity:the Danish Nationwide ENFORCE Study

20. sj-docx-1-pat-10.1177_2632010X221139096 – Supplemental material for Neurological Complications in COVID-19 Patients: Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series

21. Additional file 1 of Evaluation of HRP2 and pLDH-based rapid diagnostic tests for malaria and prevalence of pfhrp2/3 deletions in Aweil, South Sudan

22. Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial

23. Neurological Complications in COVID-19 Patients: Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series

24. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

27. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

29. Oral and constitutional manifestations of HIV-infected hospital patients in Northern Vietnam

30. ACTIV trials: cross-trial lessons learned for master protocol implementation.

31. Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19.

32. Oral and constitutional manifestations of HIV-infected hospital patients in Northern Vietnam.

Catalog

Books, media, physical & digital resources